Table 2.
B | SE | Wald | df | OR | 95% CI | P | |
---|---|---|---|---|---|---|---|
Age (y) | |||||||
<65 | 1 | ||||||
≥65 | 1.69 | 0.329 | 26.2 | 1 | 5.40 | 2.83–10.3 | <0.001 |
Albumin (g/L) | |||||||
≥35 | 1 | ||||||
<35 | 1.28 | 0.246 | 27.1 | 1 | 3.61 | 2.23–5.84 | <0.001 |
Prealbumin (mg/L) | |||||||
≥150 | 1 | ||||||
<150 | 1.06 | 0.520 | 4.14 | 1 | 2.88 | 1.04–8.00 | 0.042 |
Disease types | |||||||
Moderate cases | 1 | ||||||
Severe cases | 0.741 | 0.708 | 1.09 | 1 | 2.102 | 0.523–8.41 | 0.296 |
Critical cases | 1.50 | 0.273 | 30.1 | 1 | 4.463 | 2.62–7.64 | <0.001 |
ADL score | |||||||
100 | 1 | ||||||
61–99 | −20.6 | 8685 | 0.000 | 1 | 0.000 | 0.000 | 0.998 |
41–60 | 1.50 | 0.598 | 6.32 | 1 | 4.504 | 1.34–14.5 | 0.012 |
≤40 | 2.25 | 0.269 | 69.7 | 1 | 9.495 | 5.60–16.1 | <0.001 |
Adjusted for age, gender, BMI, albumin concentration, prealbumin concentration, disease type, ADL score, and clinical outcomes. ADL, activities of daily living; COVID-19, coronavirus disease 2019.
Severe cases vs. moderate cases.
Critical cases vs. moderate cases.
ADL score of 41–60 vs. ADL score of 100.
ADL score ≤40 vs. ADL score of 100.